E
Power Law company profile
Erkang Pharmaceutical
China · Founded 2003 · IPO 2011 Thoroughbred
Valuation
$1.19B
Market cap · May/2026
Revenue
$160M
Latest reported FY
EBITDA
$25M
Latest reported FY
Featured in
$10B+ revenueThoroughbred · Power Law outcome
Global footprint
Where Erkang Pharmaceutical has talent and traffic
Workforce by country
2
countries with
team presence
team presence
🇨🇳 China96.5%
🇰🇭 Cambodia3.5%
Web traffic by country
110
monthly visits
across markets
across markets
🇻🇳 Vietnam90.9%
🇯🇵 Japan90.9%
Market sentiment
What the market is saying about Erkang Pharmaceutical
An AI-synthesized read of the highest-engagement posts about Erkang Pharmaceutical on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Erkang Pharmaceutical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.